Two Cambridge researchers have been recognised for excellence in medical science with their election to the Fellowship of the Academy of Medical Sciences.
Two Cambridge researchers have been recognised for excellence in medical science with their election to the Fellowship of the Academy of Medical Sciences.
Professor Barry Everitt, at the Department of Experimental Psychology, and Professor Ed Bullmore, at the Department of Psychiatry, have been elected for their ‘outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge, and conspicuous service to healthcare’.
Barry Everitt, Professor of Behavioural Neuroscience, is one of the leading neuroscientists in the United Kingdom. His research is concerned with understanding the neural and psychological mechanisms underlying drug addiction, motivation, learning and memory. He has also been Master of Downing College since 2003.
"This election is highly appropriate given Barry’s contributions, specifically to the field of drug addiction and more generally to behavioural neuroscience, which I am sure will prove to be of great relevance to medicine," said Professor Trevor Robbins, Head of the Department of Experimental Psychology.
Ed Bullmore, Professor of Psychiatry, specialises in schizophrenia and other neurodevelopmental disorders, psychopharmacological effects on brain function, and the integration of imaging and genetics. After arriving at Cambridge in 1999, he established the Brain Mapping Unit. He is currently the director of functional MRI at the Wolfson Brain Imaging Centre and co-director of CAMEO, a new clinical service for patients with early symptoms of psychosis.
Professor Peter Jones, Head of the Department of Psychiatry said, “Ed Bullmore is a remarkable scientist, working in the most challenging areas of cognition and mental illness, two of the most complex spheres of clinical neuroscience. His application of mathematical approaches such as fractal geometry to structural and functional neuro-imaging experiments, together with his ability to extrapolate results to real-world clinical situations, makes him an exceptional medical scientist.
“It has been no surprise that the Clinical School’s ground-breaking arrangement with GlaxoSmithKline, seeing Professor Bullmore seconded fifty percent as Vice-President for experimental medicine while retaining his clinical academic appointment in the Department of Psychiatry and director of the University’s Brain Mapping Unit, has been such a success. I am delighted that his sustained an outstanding contributions have been recognised by his election as F Med Sci.”
Dr Michael Hastings, MRC staffer and former Fellow of Queens' College, has also been elected to the academy. The Programme Leader in Circadian Neurobiology at the MRC Laboratory of Molecular Biology, he is currently researching the molecular basis to circadian rhythms in mammals and its relevance to metabolic and neurological disease.
Professor Sir John Bell, President of the Academy of Medical Sciences said, “These Fellows enter the Academy at a time when health and medical science issues are high on the public and political agenda. Our Fellows demonstrate the wealth of experience and diversity of talent amongst the UK’s research community. Their excellence in medical research plays a pivotal role in determining the future of medical science and the benefits that society will enjoy in years to come.”
This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.
